Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 4/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.30 |
| ▸ | GBA1 | P04062 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20173448 | 0.98 | ALDH1A1 (0.44) | ALDH1A1HPGDL3MBTL1RAB9AMAPK1 | |
| SCHEMBL3706423 | 0.78 | KMT2A (0.43) | ALDH1A1HPGDL3MBTL1RAB9AMAPK1 | |
| SCHEMBL24564744 | 0.76 | KMT2A (0.46) | ALDH1A1HPGDL3MBTL1RAB9AMAPK1 | |
| SCHEMBL979441 | 0.76 | ALDH1A1 (0.45) | ALDH1A1HPGDL3MBTL1RAB9AMAPK1 | |
| SCHEMBL1200818 | 0.76 | KMT2A (0.46) | ALDH1A1HPGDL3MBTL1RAB9AMAPK1 | |
| SCHEMBL6701787 | 0.76 | ALDH1A1 (0.41) | ALDH1A1HPGDL3MBTL1RAB9AMAPK1 | |
| SCHEMBL13934134 | 0.74 | ALDH1A1 (0.47) | ALDH1A1HPGDL3MBTL1RAB9AMAPK1 | |
| SCHEMBL11266483 | 0.74 | ALDH1A1 (0.44) | ALDH1A1HPGDL3MBTL1RAB9AMAPK1 | |
| SCHEMBL15936611 | 0.71 | — | — | |
| SCHEMBL996829 | 0.70 | ALDH1A1 (0.38) | ALDH1A1HPGDL3MBTL1RAB9AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8609669-B2 | Potassium channel modulators | ABBVIE INC. (US) | 2013-12-17 | — | — | US | disclosed |
| WO-2012067822-A1 | PYRAZOLO [1, 5 -A] PYRIMIDIN POTASSIUM CHANNEL MODULATORS | ABBOTT LABORATORIES (US) | 2012-05-24 | — | — | WO | disclosed |
| US-20120122888-A1 | Potassium Channel Modulators | ABBOTT LABORATORIES (US) | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120122888-A1 | Potassium Channel Modulators | KCNQ1, KCNQ2, KCNJ2 | ALDH1A1 1773/4885HPGD 2576/4885L3MBTL1 1819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.